PRAISE: PRedictive Accuracy of Initial Stone Burden Evaluation.

Sponsor
University Hospital, Ghent (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04746378
Collaborator
EAU Young Academic Urologists Urolithiasis and Endourology Working Group (Other), European Association of Urology Section of Uro-Technology (Other), Endourological Society TOWER Research Team (Other)
1,000
1
27.7
36.1

Study Details

Study Description

Brief Summary

This study is intended to be a prospective registry of patients undergoing any kind of stone treatment that have a pre-operative CT available. This imaging will be used to measure the stone burden in three different ways: in a single dimension (cumulative stone diameter), in two dimensions (surface area) and in three dimensions (volume).The primary purpose is to identify what way of measuring stone burden is most predictive of outcomes after stone treatment such as stone free status, operative time and complications.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Computed Tomography, CSD
  • Diagnostic Test: Computed Tomography, SA
  • Diagnostic Test: Computed Tomography, 3D

Detailed Description

The current EAU and AUA guidelines still base the recommendations for stone treatment on cumulative stone diameter, a linear measurement of the stone burden. Multiple nomograms rather use the stone burden's surface area to predict post-operative outcomes. More recently, volume has been prposed as the most accurate measure of stone burden and the variable to be reported in stone treatment literature. Although inuitively a three dimensional evaluation is most likely the most accurate representation of the stone burden to be treated.

Several reports however have compared different ways of measuring stone burden and could not confidently identify volume as the most accurate predictor of surgical outcomes.

With this study, we aim to prospectively collect data on a large group of patients that have a pre-operative CT scan available. This imaging will be used to assess the stone burden in different ways, linear, two dimensional and three dimensional. Both procedural and post-operative data will be collected to identify which of the measurements is most accurate in predicting outcomes such as stone free status, operative time and complications such as bleeding. Patients can be included regardless of the procedure that is proposed to treat the stone. After inclusion and after having undergone the procedure, at least one post-operative assessment is necessary to be able to evaluate the pre-operative variables against post-operative outcomes.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparison of Predictive Value of Different Stone Burden Measurements for Outcomes After Urinary Stone Treatment.
Actual Study Start Date :
Sep 9, 2021
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
extracorporeal shockwave lithotripsy

Patients that are included in the study and undergo a shockwave lithotripsy. The pre- and postoperative assessment remains the same across groups

Diagnostic Test: Computed Tomography, CSD
Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other Names:
  • Cumulative Stone Diameter
  • Diagnostic Test: Computed Tomography, SA
    Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
    Other Names:
  • Stone Surface Area
  • Diagnostic Test: Computed Tomography, 3D
    Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
    Other Names:
  • Stone Volume
  • uretero(reno)scopy

    Patients that are included in the study and undergo a semirigid or flexible uretero(reno)scopy. The pre- and postoperative assessment remains the same across groups

    Diagnostic Test: Computed Tomography, CSD
    Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
    Other Names:
  • Cumulative Stone Diameter
  • Diagnostic Test: Computed Tomography, SA
    Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
    Other Names:
  • Stone Surface Area
  • Diagnostic Test: Computed Tomography, 3D
    Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
    Other Names:
  • Stone Volume
  • percutaneous nephrolithotomy

    Patients that are included in the study and undergo a percutaneous nephrolithotomy. The pre- and postoperative assessment remains the same across groups

    Diagnostic Test: Computed Tomography, CSD
    Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
    Other Names:
  • Cumulative Stone Diameter
  • Diagnostic Test: Computed Tomography, SA
    Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
    Other Names:
  • Stone Surface Area
  • Diagnostic Test: Computed Tomography, 3D
    Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
    Other Names:
  • Stone Volume
  • Outcome Measures

    Primary Outcome Measures

    1. Stone Free Status [1 day to 3 months]

      Any residual stone fragments after the initial treatment

    Secondary Outcome Measures

    1. Operative Time [intra-operative]

      Time needed to treat the stone burden as measured during one treatment session

    2. Complication [30 days]

      Any complication thet can be attributed to the procedure that was performed

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Availability of computed tomography imaging

    • Undergoing any of the previously described procedures: extracorporeal shockwave lithotripsy, uretero(reno)scopy or percutaneous nephrolithotomy

    • Able to read and understand the information regarding the study and able to provide informed consent

    Exclusion Criteria:
    • Under the stated age limit

    • No pre-operative computed tomography imaging available

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University Hospital Ghent Gent Eastern-Flanders Belgium 9000

    Sponsors and Collaborators

    • University Hospital, Ghent
    • EAU Young Academic Urologists Urolithiasis and Endourology Working Group
    • European Association of Urology Section of Uro-Technology
    • Endourological Society TOWER Research Team

    Investigators

    • Principal Investigator: Thomas Tailly, MD, University Hospital, Ghent

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Ghent
    ClinicalTrials.gov Identifier:
    NCT04746378
    Other Study ID Numbers:
    • B6702020000464
    First Posted:
    Feb 9, 2021
    Last Update Posted:
    Jan 24, 2022
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Ghent
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 24, 2022